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Abstract  32 
Pro-inflammatory cytokines are involved in clearance of Plasmodium falciparum, and very high levels 33 
of these cytokines have been implicated in the pathogenesis of severe malaria. In order to determine 34 
how cytokines vary with disease severity and syndrome, we enrolled Malawian children presenting 35 
with cerebral malaria (CM), severe malarial anaemia (SMA) and uncomplicated malaria (UCM), and 36 
healthy controls. We analysed serum cytokine concentrations in acute infection, and in convalescence. 37 
With the exception of IL-5, cytokine concentrations were highest in acute CM, followed by SMA, and 38 
were only mildly elevated in UCM.  Cytokine concentrations had fallen to control levels when re-39 
measured at one month of convalescence in all three clinical malaria groups.  IL-10-to-TNF-α and IL-40 
10-to-IL-6 ratios followed a similar pattern. Compared to concentrations in sera from healthy controls, 41 
children presenting with acute CM had significantly higher concentrations of TNF-α (p<0.0001), IFN-γ 42 
(p=0.0019), IL-2 (p=0.0004), IL-6 (p<0.0001), IL-8 (p<0.0001) and IL-10 (p<0.0001). Compared to 43 
those presenting with acute SMA, acute CM patients had significantly higher concentrations of IL-6 44 
(p<0.0001) and IL-10 (p=0.0003). Our findings are consistent with the concept that high levels of pro-45 
inflammatory cytokines, despite high levels of the anti-inflammatory cytokine IL-10, could contribute 46 
to the pathogenesis of CM.  47 
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Introduction  54 
Nearly 214 million clinical episodes of malaria were reported in 2015 leading to 438,000 deaths, the 55 
majority of which were among African children and attributable to P. falciparum malaria (1). Clinical 56 
P. falciparum malaria presents either as uncomplicated malaria (UCM) or as one of the following 57 
severe forms of the disease: cerebral malaria (CM), severe malarial anaemia (SMA), metabolic acidosis 58 
(MA) or respiratory distress (RD) and other complications including some overlap syndromes (1-2).  59 
Immunity to malaria is both humoral and cell-mediated and involves various mechanisms (3). 60 
Antibodies that develop through exposure to P. falciparum play a role (3), and the involvement of 61 
different lymphocyte subsets has been implicated in both protection against, and pathogenesis of 62 
malaria (4 - 6).  63 
 64 
Cytokines are regulatory proteins or glycoproteins secreted by white blood cells and various other cells 65 
in response to a number of stimuli (7). ‘Cytokine’ is a general term, but cytokines have more specific 66 
names depending on the type of cells that produce them and on the functions they perform, such that 67 
lymphokines are produced by lymphocytes, and monokines by monocytes and macrophages (8). 68 
Lymphokines, such as interferon-gamma (IFN-γ), and interleukin 4 (IL-4) stimulate B cells to produce 69 
antibodies, attract and activate immune cells such as macrophages and other lymphocytes at sites of 70 
infection. (8 - 11). In contrast, monokines such as Tumor Necrosis factor alpha (TNF-α), IL-1, IL-6 71 
and IL-8, play roles that are inflammatory in nature and also attract neutrophils by chemotaxis (9 - 10). 72 
However, it is clear now that the majority of cytokines can be produced by a range of different cell 73 
types, questioning the apparent specificity of ‘lymphokine’ and ‘monokine’. 74 
 75 
 76 
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 77 
Cytokines can also be grouped based on the T cells that produce them when the T cells are stimulated 78 
to differentiate. T helper 1 (Th1)  cells are known to produce large quantities of IFN-γ, induce delayed 79 
hypersensitivity reactions, activate macrophages and are crucial for the defence against intracellular 80 
pathogens (11 – 12) whereas Th17 cells produce IL-17, IL-21 and IL-22 (11). Th2 cells produce IL-4 81 
and are important in inducing IgE production, recruiting eosinophils to sites of inlammation and 82 
helping clear parasitic infections (8, 11). 83 
 84 
When categorised based on their effect on inflammation, cytokines can either be termed pro-85 
inflammatory, with the cytokines IL-1, TNF-α, IFN-γ, IL-12 and IL-18 included in this group, while 86 
cytokines such as IL-4, IL-10, IL-13 and transforming growth factor beta (TGF-β) are reffered to as 87 
anti-inflammatory cytokines (12 - 13). Pro-inflammatory cytokines are produced by a multiplicity of 88 
cells including lymphocytes, monocytes, macrophages, fibroblasts, neutrophils, endothelial cells and 89 
mast cells and are known to be involved in clearing the initial parasitaemia in the early stages of P. 90 
falciparum infection (7, 14 - 15). Pro-inflammatory cytokines such as TNF-α (16), IFN-γ, IL-6 and IL-91 
1 (17 - 18), when produced in an unregulated manner, have been implicated in the pathogenesis of 92 
cerebral malaria (19), and correlate with disease severity and death (20).  93 
 94 
In contrast, anti-inflammatory cytokines such as IL-10 have been shown to down-regulate the pro-95 
inflammatory cytokines (15, 21). Experiments in which IL-10 was administered in mice models of 96 
malaria resulted in production of lower TNF-α and lower incidence of experimental cerebral malaria 97 
(ECM) (22 - 23), leading some to hypothesise that IL-10 counteracts the potentially pathological host 98 
pro-inflammatory response to malaria (14). 99 
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 100 
Inflammatory cytokines also play an important role in the pathogenesis of SMA, with high levels of 101 
TNF-α, but low levels of IL-10 (24), being associated with SMA in areas of high malaria endemicity 102 
(24 -25). IL-12 has been shown to be involved in protective immunity against malaria by regulating 103 
IFN-γ, TNF-α and nitric oxide responses in experimental studies (26) and enhancing erythropoiesis in 104 
P. chabaudi-infected susceptible mice (27). 105 
 106 
Although cytokines may act on the same cells that secrete them (autocrine action), or on cells within 107 
close proximity (paracrine action) or in some cases at distant cells (endocrine action) (8), in vitro 108 
assays can only either measure proportions of cytokine-producing cells by intracellular cytokine 109 
staining or quantify cytokine concentration in serum or plasma samples extracted from stimulated or 110 
unstimulated venous blood samples using commercially-available enzyme immunoassays (28). We 111 
analysed serum samples of children presenting with different clinical presentations of malaria during 112 
acute infection and in convalescence, together with samples from healthy children, in order determine 113 
concentrations of different cytokines. 114 
115 
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Materials and Methods 116 
Study Area and Study Population 117 
The study was conducted within the Malawi-Liverpool-Wellcome Trust Clinical Research Programme 118 
and Department of Paediatrics, College of Medicine, University of Malawi, and Blantyre Malaria 119 
Project. Participants were children admitted with acute malaria to Queen Elizabeth Central Hospital 120 
(QECH), and medically-well children attending surgical outpatient clinics at QECH and Beit Cure 121 
International Hospital, both in Blantyre, Malawi. Demographic and clinical features of the participants 122 
have been reported previously (6). In brief, children were enrolled during the rainy season (November 123 
2005 to April 2006) after obtaining informed consent from the parent or guardian. Each child was 124 
examined by a research nurse and clinical officer, baseline demographic data were recorded and a 125 
venous blood sample was collected. Criteria defining clinical malaria were: fever, a clinical syndrome 126 
compatible with malaria without any apparent alternative cause, and a thick blood film positive for 127 
Plasmodium falciparum asexual parasites on microscopy. Children were assessed for level of 128 
consciousness using the Blantyre Coma Score (BCS) on admission and at two- to-four hourly intervals 129 
during intensive clinical care. Over forty children were prospectively enrolled into each of the four 130 
clinical groups defined by diagnoses of cerebral malaria (CM), severe malarial anemia (SMA) or 131 
uncomplicated malaria (UCM), or healthy controls.  132 
Children with CM had a BCS of two or less at admission and four hours later, while children in all 133 
other groups had a score of five at both times (Table 1). Children with SMA had a blood haemoglobin 134 
concentration of 5 g/dl or less, and all other children had a haemoglobin concentration above 5 g/dl . 135 
Children who tested positive for HIV infection were excluded from the study and referred to the 136 
antiretroviral therapy clinic. Children who presented with UCM or SMA were treated with a standard 137 
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regimen of sulfadoxine-pyrimethamine (SP), which was the first line treatment for malaria in Malawi at 138 
the time the study was conducted. In contrast, children presenting with CM were treated with 139 
intramuscular (IM) quinine as recommended for CM patients at that time. Study participants in the 140 
UCM, SMA and CM groups were seen again approximately 30 days after treatment (convalescence or 141 
follow-up (F) visit), at which time a second blood sample was collected.  142 
 143 
Malaria Microscopy 144 
Thick and thin films were prepared for determining the density of malaria parasitemia.  145 
Preparation and reading of malaria slides were performed in accordance with standard WHO 146 
procedures (29). Briefly, two blood slides were prepared from each participant’s blood sample. Each 147 
slide had a measured volume of 6 μl of blood for thick film and 2 μl for the thin film.  A 3% working 148 
stock of Giemsa stain was prepared using a principal Giemsa-staining stock solution and Giemsa buffer 149 
prepared from buffer tablets. Thin and thick blood smears were stained with Giemsa after fixing the 150 
thin smear with absolute methanol. The stained slides were read by two competent, independent 151 
malaria microscopists. The entire smear was first screened at a low magnification (10X and 40X 152 
objective lens) to detect suitable fields with even distribution of white blood cells (WBC) (10–20 153 
WBC/field). Smears were then examined using 100X oil immersion lens. At least 100 low power fields 154 
were examined before a thick smear was declared negative.  A blood slide was declared positive when 155 
a concordant result was produced by the microscopists.  P. falciparum parasites were counted per 200 156 
or 500 leukocytes, in order to estimate the parasite density per microliter of blood. Discordant results 157 
were resolved by a third reading of the films. Thin films were examined to confirm the species of the 158 
infecting Plasmodium.  159 
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HIV and malaria tests 160 
HIV testing was performed using two rapid tests, Determine (Abbott Laboratories, Tokyo) and 161 
UniGold (Trinity Biotech, Dublin). Discordant results and positive results in children under 18 months 162 
were confirmed by PCR as previously described (30).  163 
 164 
Serum Collection and preservation 165 
Whole blood samples from study participants were collected on admission and prior to administering 166 
antimalarial therapy and one month after treatment as previously described (6). An aliquot of the blood 167 
sample was collected in a plain tube and allowed to coagulate with serum separation by centrifugation. 168 
Serum was divided into aliquots and preserved at -80oC until required for cytokine analysis. 169 
 170 
Cytokine analysis 171 
Concentrations of various cytokines were determined using Becton Dickson (BD) CBA (Cytokine 172 
Bead Array) kits. Sera were thawed and centrifuged at maximum speed for 10 minutes to remove fibrin 173 
deposits. 25μl of each sample was mixed with 25μl of the capture bead mixture and then with 25μl of 174 
detection reagent. Subsequent steps were performed according to manufacturer’s instructions (BD 175 
CBA Instruction Manuals, 2006). The kit sensitivity (minimum detectable concentration) limits for the 176 
various cytokines are provided in Table S1. 177 
 178 
 179 
 180 
 181 
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Statistical Analysis  182 
Statistical tests were performed using GraphPad Prism version 6.01 for Windows (GraphPad Software, 183 
San Diego California USA). Kruskall Wallis Test was used to compare the medians of the different 184 
cytokine concentrations (pg/ml) and ratios in different clinical groups. Between-group comparisons of 185 
cytokine concentrations for the four groups (Controls, UCM, SMA and CM) were assessed with 186 
Bonferroni’s multiple comparison test and p value of <0.0125 was considered statistically significant. 187 
The Wilcoxon matched pairs test was used to determine the statistical significance of the differences 188 
concentrations and ratios observed during acute infection and in convalescence for each clinical 189 
syndrome of malaria and a p value of <0.05 was considered statistically significant. 190 
 191 
Ethical Approval 192 
The study was approved by the College of Medicine Research and Ethics Committee, University of 193 
Malawi, and Ethics Committee of the Liverpool School of Tropical Medicine, UK. 194 
 195 
196 
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Results 197 
 198 
Characteristics of study children  199 
 200 
The number of participants recruited in each group and their demographic and haematological 201 
characteristics have been published previously (6) and are presented in Table 1. Briefly, consent was 202 
obtained for 188 children aged 5 to 84 months to participate in the study. Blood samples from 33 203 
children were excluded for the following reasons: HIV infection (n=14), malaria parasites in the blood 204 
of control subjects (n=14), BCS greater than 2 at 4 hours post-admission in children with suspected 205 
CM (n=4), and hemoglobin below 5 g/dL in one child with CM. Five children (four with CM and one 206 
with SMA) died days after therapy had been administered.  207 
 208 
Cytokine concentrations during acute infection and in convalescence. 209 
The median concentration of IFN-γ (Fig. 1A, Table S1) was significantly (p=0.0019) higher in acute 210 
CM cases (17.3 pg/ml) than in controls (2.32pg/ml) and in acute SMA (p=0.025) and acute UCM 211 
(p=0.029) which then decreased significantly (p<0.001) in convalescence (Fig. 2A). TNF-α levels 212 
during acute disease were higher in all types of clinical malaria compared to controls (Fig 1B) with 213 
significant (p<0.001) differences observed between CM patients (median 3.76 pg/ml) and controls 214 
(median 1.41 pg/ml), and between SMA patients (median 2.95 pg/ml) and controls. UCM patients also 215 
had significantly (p=0.0012) higher TNF-α levels (2.12 pg/ml) than controls (1.41 pg/ml), but 216 
significantly (p=0.0006) lower levels than CM cases (median 3.76 pg/ml). TNF-α levels decreased 217 
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significantly in convalescence (Fig. 2B) for both CM (median 3.76 pg/ml falling to 1.69 pg/ml; 218 
p=0.002) and in SMA (median 2.95 pg/ml falling to 1.80 pg/ml; p=0.0002). 219 
Acute CM (2.48 pg/ml) patients had significantly (p=0.0009) higher median concentrations of IL-1β 220 
than controls (median 1.89 pg/ml) during acute infection (Fig. 1C), and surprisingly the level in the 221 
CM group remained elevated median (3.09 pg/ml) in convalescence (Fig 2C). SMA patients had 222 
significantly (p=0.0358) higher median concentrations of IL-1β during convalescence (median 3.34 223 
pg/ml) than during acute disease (median 2.21 pg/ml) (Fig. 2C).   224 
Both CM patients (median 3.34 pg/ml) and SMA patients (median 2.55 pg/ml) had significantly higher 225 
(p<0.001) levels of IL-2 in acute disease than in controls (2.12 pg/ml) (Fig.1D). Levels in both CM and 226 
SMA were significantly higher (p<0.05) than levels in acute UCM (2.02 pg/ml). IL-2 levels in 227 
convalescence in all malaria types were similar to controls (medians: 1.60 pg/ml for UCM, 1.30 pg/ml 228 
for SMA, 1.65 pg/ml for CM) (Fig. 2D). 229 
On admission CM (median 3.62 pg/ml) and SMA (median 2.03 pg/ml) groups had significantly 230 
(p=0.0006 for CM and p=0.0037 for SMA) higher concentrations of IL-4 than controls (median 1.41 231 
pg/ml) (Fig. 1E), levels in the disease groups decreasing in convalescence (Fig. 2E). IL-4 levels in 232 
acute CM were significantly (p<0.001) higher than those in acute SMA and UCM (median 1.49 pg/ml). 233 
Concentrations of IL-5 in acute infection of all three types of malaria were similar to those of healthy 234 
controls (Fig. 1F) although the levels of IL-5 in acute CM (median 1.74 pg.ml) were significantly 235 
higher (p<0.001) compared to the levels in UCM (median 1.54 pg.ml). IL-5 levels in all three malaria 236 
types were similar in acute infection and in convalescence (Fig. 2F). 237 
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IL-6 levels in all three malaria types (medians: 17.31 pg/ml for UCM, 12.20 pg/ml for SMA and 156.3 238 
pg/ml for CM) were significantly (p<0.0001) higher during acute disease than in controls (2.37 pg/ml) 239 
(Fig G). Among the three malaria types, CM patients had the highest IL-6 levels and the difference 240 
between the levels in acute SMA and CM and between acute UCM and CM were significant 241 
(p<0.0001). All three malaria types had significantly (p<0.0001) lower IL-6 levels (medians: 1.90 242 
pg/ml for UCM, 2.09 pg/ml for SMA and 1.87 pg/ml for CM) in convalescence (Fig. 2G) than in acute 243 
infection. 244 
During acute illness (Fig. 1H) IL-8 levels were higher in all malaria types (medians: 8.47 pg/ml UCM, 245 
p=0.031; 13.03 pg/ml for SMA, p=0.0002; and 29.71 pg/ml for CM, p<0.0001) than in controls 246 
(median 6.55 pg/ml). IL-8 concentrations in CM patients were significantly (p<0.0001) higher than in 247 
both SMA and UCM patients. In convalescence IL-8 levels had significantly decreased in all three 248 
malaria types (p=0.0059 for UCM and p<0.0001 for SMA and CM) (Fig. 2H).  249 
During acute illness median IL-10 levels were significantly (p<0.0001 for UCM, SMA and CM) higher 250 
in children presenting with each of the malaria syndromes than in controls (Fig. 1I). Similar to the 251 
trend for IL-8, levels of IL-10 in acute SMA and UCM patients were significantly (p<0.0001) lower 252 
than in acute CM. IL-10 levels in all malaria groups were significantly (p<0.0001) lower in 253 
convalescence (medians: 4.13 pg/ml UCM, 4.50 pg/ml for SMA and 4.64 pg/ml for CM) than in acute 254 
disease (Fig. 2I). Patients presenting with acute CM had significantly (p=0168) higher levels of IL-255 
12p70 (median 2.09 pg/ml) than controls (median 1.52 pg/ml) (Fig. 1J). Levels of IL-12p70 were 256 
similar in acute infection and convalescence (Fig. 2J).  257 
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IL-12 is the main driver of the IFN-γ response in the T helper 1 pathway, and so, perhaps surprisingly, 258 
IL-12p70 was only significantly elevated in CM compared with controls, but only to a modest degree 259 
(medians: 2.13 pg/ml and 1.52 pg/ml, p=0.0168). 260 
CM patients (n=4) and one SMA patient who had died had significantly (p<0.05) higher levels of all 261 
cytokines (Fig 3, Table 2) during acute illness than those who survived (n=25). 262 
 263 
Comparison of IL-10/TNF-α and IL-10/IL-6 ratios between different groups 264 
The IL-10-to-TNF-α ratio was significantly (p<0.0001) higher in acute UCM, SMA and CM (medians: 265 
43.25, 25.16 and 140.2 respectively) patients than in controls (median 3.47), while the ratio in acute 266 
SMA was significantly (p<0.0001) lower than the ratio in acute CM (Fig. 1K). The IL-10-to-TNF-α 267 
ratios for all three malaria types (medians: 2.10 for UCM, 2.60 for SMA and 3.65 for CM) in 268 
convalescence were similar to ratios in controls (median 1.63) (Fig. 2K).  269 
The IL-10-to-IL-6 ratios in acute UCM, SMA and CM (medians: 4.58, 3.92 and 2.93 respectively) 270 
were significantly (p<0.0001 for UCM, p=0.0003 for SMA and p=0.0090 for CM) higher than the ratio 271 
in controls (median 1.63) (Fig. 1L and Table 2). During convalescence, UCM (median 2.20) still had 272 
significantly (p=0.0149) higher IL-10-to-IL-6 ratio than controls (median 1.63) but SMA (median 2.20) 273 
and CM (median 2.20) ratios were just as low as those of controls. (Fig. 2L and Table S1). 274 
275 
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Discussion 276 
Cytokine production by different cell types in response to foreign antigen is one of the defence 277 
mechanisms that characterise cellular immunity and can drive both normal and pathological immune 278 
responses (7). Previous studies have shown that when pro-inflammatory cytokines (produced by a 279 
variety of cells, including Th1 cells and macrophages) such as TNF-α (16), IFN-γ, IL-6 and IL-1 (17 - 280 
18), are produced in an unregulated manner, they contribute towards pathogenesis of cerebral malaria 281 
(19), and to disease severity and death (20). In contrast, anti-inflammatory cytokines (produced by cells 282 
that include monocytes and Th2 cells) such as IL-10 and IL-13 have been shown to down-regulate 283 
production of pro-inflammatory cytokines (15, 21) and to reduce the incidence of experimental cerebral 284 
malaria (ECM) in mice models (22). 285 
 286 
We analysed concentrations of serum cytokines in Malawian children presenting with CM, SMA and 287 
UCM in acute illness and in convalescence, and compared these levels with those in healthy controls 288 
(Table S1 and Table 2). We found that both pro-inflammatory (TNF-α, IFN-γ, IL-1, IL-6) and anti-289 
inflammatory cytokine (mainly IL-10) concentrations were markedly elevated over control levels in 290 
Malawian children presenting with CM, moderately raised in SMA patients and minimally, but 291 
significantly increased in those children presenting with UCM.  In all patient groups, cytokine 292 
concentrations decreased to control levels in convalescence. A similar trend was observed for IL-10-to-293 
TNF-α and IL-10-to-IL-6 ratios. These results indicate that acute malaria, regardless of severity, is 294 
characterised by higher than normal levels of a broad range, but not all, of cytokines, whether in the 295 
‘Th1 group’ (IFN-γ, TNF-α and IL-1) or ‘Th2 group’ (IL-4, IL-6 and IL-10). These high levels 296 
decrease significantly in convalescence.  297 
 298 
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In line with our findings, most studies that have determined cytokine concentrations in Plasmodium 299 
malaria, both in mouse models (22, 26-27) and in humans (14, 17, 21, 23, 12, 31-43), have reported 300 
highly elevated cytokine concentrations in symptomatic malaria of all clinical varieties.  Although 301 
murine studies provide some insight into malaria-related cytokine perturbations, data from humans 302 
with various malaria syndromes are essential for understanding the pathogenesis of human disease.  303 
 304 
Among the various studies that have investigated cytokine perturbation in P. falciparum malaria in 305 
other countries (12, 31-43), few have compared the levels in the different clinical types of malaria, 306 
namely UCM, SMA and CM (12, 14). TNF-α, IFN-γ, IL-1, IL-6, IL-8 and IL-10 have been found in 307 
increased levels in patients with severe malaria compared to healthy controls (14, 25) decreasing in 308 
convalescence to control levels, but in these studies the clinical syndromes of severe malaria were not 309 
fully described. Cytokine data from children presenting with strictly-defined UCM, SMA and CM and 310 
a month in convalescence in this study provide additional valuable information.  311 
 312 
Interestingly, there are some apparent paradoxes between the cytokine concentrations reported in the 313 
current manuscript and monocyte intracellular cytokine staining (44) and immunophenotyping findings 314 
(6) that we have reported previously for the same study participants. We observed decreased IL-6 and 315 
TNFα production by monocytes in children with difference forms of malaria (44), This indicates that 316 
the elevated serum levels of these cytokines in the current report are produced by cells other than 317 
monocytes (or macrophages), most likely T cells and NK cells. Moreover, we reported 318 
panlymphopenia among children with cerebral malaria and uncomplicated malaria. Therefore, elevated 319 
cytokine production by lymphocytes in these groups would either have to come counterintuitively from 320 
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a reduced number of peripheral blood lymphocytes, or from lymphocytes retained in secondary 321 
lymphoid tissues or sequestered in other vascular structures.  322 
 323 
Not all malaria-infected children with high levels of Th1 pro-inflammatory cytokines, such as TNF-α, 324 
develop severe malaria (14), suggesting that the cytokine network as a whole, rather than a single 325 
cytokine, may contribute in different ways to severe disease (12, 25). Thus, severe P. falciparum 326 
malaria could be associated with an inadequate negative feedback response by Th2 anti-inflammatory 327 
cytokines such as IL-10. The timing of IL-10 production is likely to be important in determining its 328 
effectiveness as an anti-inflammatory cytokine with in vitro studies showing that TNF-α, IL-6 and IL-329 
1β are produced within 2 to 4 hours of stimulation, while IL-10 is first detected after 8 hours 330 
supporting the concept that IL-10 counter-regulates the pro-inflammatory response to P. falciparum 331 
(12). Our in vitro observations that IL-10 was detected 7 hours after activation of monocytes with LPS 332 
and maximal IL-10 levels were only observed after 24 to 48 hours of stimulation with LPS (45) are 333 
consistent with this concept. 334 
Since IL-10 serves to regulate both the production and functions of TNF-α and IL-6 (19, 45), it has 335 
been suggested that children with a low IL-10-to-TNF-α ratio may be more likely to develop severe 336 
malaria compared to children with a higher ratio (14). In a study from Kenya (25), children with severe 337 
malaria (type of severe malaria was not specified) had higher IL-10-to-TNF-α ratios compared to 338 
children presenting with mild disease. Here we found that Malawian children presenting with all forms 339 
of malaria had high IL-10-to-TNF-α and IL-10-to-IL-6 ratios, so high levels of TNF-α and IL-6 in CM 340 
could not be attributed to a lack of IL-10 response. Nevertheless, it is apparent that the IL-10 response 341 
observed in CM was unable to prevent these high pro-inflammatory cytokine levels since higher levels 342 
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of IL-6 and TNF-α in malaria patients who died than in those who survived, as found previously in 343 
adults in Vietnam (19), suggest that uncontrolled levels of these cytokines may have contributed to the 344 
demise of these children.  In a separate study in Malawian children, those presenting with severe 345 
malaria had higher levels of IL-6 and TNF-α compared to those presenting with UCM although severe 346 
malaria was not further sub-categorised (31).  347 
 348 
 349 
Overall, the observation that higher levels of the pro-inflammatory/Th1 cytokines were found in CM 350 
compared with SMA is consistent with the concept that CM results from an immunopathological 351 
response in which the production of pro-inflammatory cytokines are poorly regulated (19, 45). Other 352 
investigators have argued that early, as opposed to late, production of IFN-γ and TNF-α correlates well 353 
with protection since when produced early, over-production can more easily be kept in check by the 354 
presence of anti-inflammatory cytokines such as IL-10 (32).    355 
 356 
The present study was limited in that the analysed blood samples were collected only at two time 357 
points, acutely and once in convalescence at time points which were roughly 30 days apart. It would be 358 
informative to conduct a longitudinal study recruiting children that present with different forms of 359 
malaria who are then followed closely to provide a time course curve for these cytokines as has been 360 
done before with blood samples from South African adults (39), although these were followed for only 361 
five days.  362 
An unavoidable limitation of clinical studies of natural infection is that we do not know the point in 363 
time at which Plasmodial sporozoites are first inoculated by the mosquito, nor the time when 364 
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merozoites first emerge from the liver to invade erythrocytes.  Although we have reported on the 365 
proportion of cytokine-producing monocytes from each of these three malaria groups (44), inclusion of 366 
an intracellular cytokine analysis for other cytokine-producing cells, could enable identification of the 367 
main producers of the cytokines present in corresponding serum/plasma. Lastly, although this study 368 
analysed serum samples for concentrations of some cytokines, analysis of additional cytokines that are 369 
suspected to play some roles in malaria immunity (42-43) as well as concentrations of chemokines 370 
such as RANTES and IP-10, which have been shown to vary with malaria severity (42), would provide 371 
additional insight into their separate and/or synergistic roles in malaria. Subsequent studies should 372 
combine analysis of serum or plasma samples for cytokines with intracellular cytokine staining, in 373 
samples collected from children presenting with different forms of clinical malaria.   374 
We have shown that, just as different clinical malaria syndromes are characterised by diverse 375 
perturbations of leukocyte and lymphocyte subsets (6), they are also characterised by altered cytokine 376 
patterns.  While in acute CM there is a transient pan-lymphopenia (6), and lowest proportion of IL-6 377 
and TNF-α producing monocytes (44), there is a paradoxical concomitant elevation of circulating 378 
cytokine levels, with all perturbations normalising in convalescence (6, 44). Many studies of cytokine 379 
levels in malaria have been published, yielding generally similar findings. In this paper, however, we 380 
bring together various malarial syndromes, different classes of cytokines and admission and 381 
convalescent time-points in the same group of children, in whom circulating leucocyte counts and 382 
lymphocyte subsets have already been quantitated. The question as to why the cells that might have 383 
been expected to increase in association with their secretory product actually decrease during acute 384 
illness (6) could be addressed by the hypothesis that the secretory cells get sequestered in secondary 385 
lymphoid tissue during acute disease. Whereas the observation of high cytokine levels in acute disease 386 
but low proportion of cytokine producing monocytes (44) could be explained by the hypothesis that the 387 
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monocytes responsible for producing the observed high cytokine levels are anergic to further 388 
stimulation during the phase of acute disease when a venous sample is collected.     389 
 390 
Our findings support the suggestion that cytokines, particularly in CM, may promote the transient 391 
sequestration of lymphocytes in secondary lymphoid tissue, potentially causing the observed 392 
paradoxical lymphopenia (6) by contributing to the upregulation of CD69 that is recognized in CM 393 
(46). The differences in cytokine levels between CM and other malarial syndromes may reflect the 394 
severity of the disease (CM has the highest case fatality rate among these syndromes) and/or the 395 
parasite burden, which in most studies that include these three syndromes, is greatest in CM (2). 396 
 397 
With developing technologies for bedside diagnosis, patterns of circulating cytokine concentrations 398 
may in due time contribute to the rapid differentiation between malaria and other causes of fever.  For 399 
this possibility to be realized, increased amounts of data on immunological and biochemical 400 
parameters, including cytokine levels, will need to be gathered from clinically well-characterised 401 
patients, so that new tests can be evaluated for their practical usefulness.  402 
403 
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Figure Legends 404 
Figures 1A to 1J): Plots of log transformed concentrations (pg/ml) of different cytokines (IFN-γ, TNF-405 
α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10 and IL-12p70) in sera samples collected from healthy 406 
controls (Control), acute uncomplicated malaria (UCM), acute severe malarial anaemia (SMA) and 407 
acute cerebral malaria (CM). Figures 1K and 1L are plots of the ratio of log transformed IL10-to-408 
TNF-α and IL-10-to-IL-6 respectively during acute infection. (Medians and 10th and 90th percentiles) 409 
 410 
Figures 2A to 2J: Plots of log transformed concentrations (pg/ml) of different cytokines (IFN-γ, TNF-411 
α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10 and IL-12p70) in sera samples collected from healthy 412 
controls (Control) and from convalescent uncomplicated malaria patients (UCM-F), severe malarial 413 
anaemia (SMA-F) patients and cerebral malaria (CM-F) patients. Figures 2K and 2L are plots of the 414 
ratio of log transformed IL10-to-TNF-α and IL-10-to-IL-6 respectively during convalescence (Medians 415 
and 10th and 90th percentiles). 416 
 417 
Figure 3: Cytokine levels in children with CM and SMA who died and survived: Plot of log 418 
transformed concentrations (pg/ml) of different cytokines (IFN-γ, TNF-α, IL-1β, IL-2, IL-4, IL-5, IL-6, 419 
IL-8, IL-10 and IL-12p70) in sera samples collected from five children who died (red dots) and those 420 
children who survived (black dots) after presenting with acute CM and SMA (Medians and 10th and 421 
90th percentiles) 422 
 423 
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 Clinical Group Controls 
Cerebral 
Malaria 
Severe 
Malarial Anemia 
Uncomplicated 
Malaria 
Number 42 29 30 54 
Died after Recruitment - 4 1 0 
Reviewed in 
Convalescence - 18 21 34 
Sex (M:F) 29:13 10:19 19:11 38:16 
Age (months) 
(range) 
20 
(5 - 76) 
30 
(5 - 84) 
23 
(5 - 38) 
27 
(6 - 58) 
Parasites/µl blood) 
(range) 0 
41,800 
(900 - 517,000) 
3,500 
(20 - 296,000) 
52,300 
(460 - 768,000) 
Blantyre Coma Score 
(range) 
5 
- 
1 
(0-2) 
5 
- 
5 
- 
Hemoglobin (g/dL) 
(range) 
11.2 
(7.0 - 14.1) 
7.7 
(5.3 - 12.5) 
3.9 
(2.4 - 4.9) 
9.3 
(5.0 - 13.0) 
 
Table 1: Demographic and clinical details of study participants: Subjects were children with cerebral 
malaria, severe malarial anemia and uncomplicated malaria presenting to the Pediatric Accident and 
Emergency Clinic at Queen Elizabeth Central Hospital in Blantyre, Malawi. Control subjects were 
children admitted for elective surgical procedures who were medically well. Values are medians and 
range. These participants’ details have been published previously (Mandala et al, CVI 2015 (6))
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Table 2: Median concentrations (pg/ml) of different cytokines (IFN-γ, TNF-α, IL-1β, IL-2, IL-4, 
IL-5, IL-6, IL-8, IL-10 and IL-12p70) in sera samples collected from five children who died (n=4 
for CM and n=1 for SMA) and those children who survived after presenting with acute CM 
(n=11) and SMA (n=14). The p values for the differences in cytokine concentrations between 
those died and those who survived. 
 
 Median Concentration (pg/ml) P value 
Cytokine Dead (n=5) Survivors (n=25)  
IFN-γ  2.22 0.94  0.0030 
TNF-α  1.23 0.76  0.0543 
IL-1β  1.125 0.385  0.0010 
IL-2  0.805 0.45  0.0012 
IL-4  0.75 0.425  0.0065 
IL-5  0.59 0.22  0.0009 
IL-6  2.33 1.84  0.0061 
IL-8  2.24 1.24  0.0007 
IL-10  3.65 2.34  0.0039 
IL-12p70  0.38 0.22  0.0035 
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